As we have previously demonstrated the expression of uPARAP in three human mesothelioma cell lines in vitro (8), we first examined their capability to form solid subcutaneous tumors in NSG mice, enabling ADC treatment studies in vivo. This evidence concerns the gene MRC2 and mesothelioma.